Insider Transactions in Q4 2022 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 30
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-49.34%
|
$6,250,000
$125.9 P/Share
|
Nov 30
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+32.62%
|
$2,000,000
$40.34 P/Share
|
Nov 29
2022
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,331
-49.63%
|
$282,051
$121.9 P/Share
|
Nov 10
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.64%
|
$12,500
$125.36 P/Share
|
Nov 10
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.63%
|
$4,100
$41.78 P/Share
|
Nov 08
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
5,592
-27.02%
|
$693,408
$124.99 P/Share
|
Nov 08
2022
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,592
+21.27%
|
$452,952
$81.05 P/Share
|
Nov 08
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,082
-14.81%
|
$635,250
$125.04 P/Share
|
Nov 08
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,082
+12.9%
|
$218,526
$43.24 P/Share
|
Nov 08
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
24,593
-61.12%
|
$3,074,125
$125.33 P/Share
|
Nov 08
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,593
+37.94%
|
$1,008,313
$41.78 P/Share
|
Nov 03
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,518
-13.39%
|
$564,750
$125.02 P/Share
|
Nov 03
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,518
+11.81%
|
$194,274
$43.24 P/Share
|
Nov 03
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,264
-32.48%
|
$908,000
$125.0 P/Share
|
Nov 03
2022
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,264
+24.52%
|
$588,384
$81.05 P/Share
|
Nov 03
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,968
-36.44%
|
$1,121,000
$125.02 P/Share
|
Nov 03
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,968
+26.71%
|
$367,688
$41.78 P/Share
|
Nov 02
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,144
-7.04%
|
$141,856
$124.97 P/Share
|
Nov 02
2022
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,144
+6.58%
|
$92,664
$81.05 P/Share
|
Nov 02
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
400
-2.49%
|
$50,000
$125.0 P/Share
|
Nov 02
2022
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+2.43%
|
$16,400
$41.78 P/Share
|
Nov 02
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
400
-1.35%
|
$50,000
$125.0 P/Share
|
Nov 02
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.33%
|
$17,200
$43.24 P/Share
|
Nov 01
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-25.49%
|
$1,200,000
$120.09 P/Share
|
Nov 01
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+20.31%
|
$430,000
$43.24 P/Share
|
Oct 31
2022
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
15,000
-6.86%
|
$1,710,000
$114.76 P/Share
|
Oct 31
2022
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.42%
|
$180,000
$12.71 P/Share
|
Oct 31
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,295
-30.73%
|
$147,630
$114.12 P/Share
|
Oct 27
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,923
-14.41%
|
$566,145
$115.04 P/Share
|
Oct 27
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,923
+12.6%
|
$211,689
$43.24 P/Share
|
Oct 26
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,077
-14.8%
|
$583,855
$115.02 P/Share
|
Oct 26
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,077
+12.89%
|
$218,311
$43.24 P/Share
|
Oct 17
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,960
-24.07%
|
$545,600
$110.82 P/Share
|
Oct 04
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-25.49%
|
$1,110,000
$111.04 P/Share
|
Oct 04
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+20.31%
|
$430,000
$43.24 P/Share
|
Oct 04
2022
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$550,000
$110.54 P/Share
|
Oct 03
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,437
-25.43%
|
$152,322
$106.59 P/Share
|